The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.20
Bid: 123.00
Ask: 123.40
Change: -0.80 (-0.65%)
Spread: 0.40 (0.325%)
Open: 124.20
High: 124.20
Low: 123.20
Prev. Close: 124.00
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

15 Dec 2014 10:00

RNS Number : 6532Z
HICL Infrastructure Company Ld
15 December 2014
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE INCLUDING IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR TO U.S. PERSONS.

15 December 2014

 

HICL Infrastructure Company Limited (the "Company" or "HICL")

 

Issue of equity

 

Introduction

 

The Board of HICL today announces a proposal to raise approximately £25 million through an issue of Ordinary Shares in the capital of the company (the "New Ordinary Shares") by way of tap issuance (the "Issue"). The Issue will be made to qualifying investors* through HICL's corporate broker, Canaccord Genuity Limited ("Canaccord Genuity").

 

Although the Company had not originally envisaged undertaking an equity raising in the near term given the imminent receipt of proceeds from the portfolio investment which it has contracted to sell, certain other investment acquisition opportunities have progressed more rapidly than expected. Against this backdrop the Board deems it prudent to raise equity now to repay some of the drawings under its £150m revolving credit facility to ensure that there is sufficient capacity to finance these new opportunities ahead of receiving the disposal proceeds.

 

Details of the Issue and expected timetable

Under the terms of the Issue, HICL intends to issue up to 17 million Ordinary Shares of 0.01 pence each in the capital of the Company, under authority granted by Shareholders at its Annual General Meeting on 22 July 2014.

 

The Issue will be non pre-emptive and will be launched immediately following this announcement, when Canaccord Genuity will commence a bookbuilding process to determine the level of demand from potential investors for participation in the Issue. The number of New Ordinary Shares to be issued and the price per Share (the "Strike Price") will be agreed between Canaccord Genuity and the Company following close of the bookbuild at noon on Wednesday 17 December, and announced shortly thereafter. Canaccord Genuity and the Company reserve the right to set a maximum percentage of New Ordinary Shares that may be allocated to any one investor.

 

The New Ordinary Shares are not being offered at a fixed price. To bid in the bookbuild, investors should communicate their bid (or bids) by telephone to their usual sales contact at Canaccord Genuity. Each bid should state the number of New Ordinary Shares for which the prospective investor wishes to subscribe and the price or price range that the prospective investor is offering to pay; any bid price must be for a full pence or half pence amount. No more than 17 million New Ordinary Shares will be issued in aggregate. The Strike Price will be in excess of the Company's prevailing net asset value per Ordinary Share.

The bookbuild is expected to close at noon (London time) on 17 December 2014 but may be closed earlier or later at the discretion of the Company and Canaccord Genuity. Canaccord Genuity may, in agreement with the Company, accept bids that are received after the bookbuild has closed.

Subject to the above, Canaccord Genuity may choose to accept bids, either in whole or in part, on the basis of allocations determined in agreement with the Company, and may scale down any bids for this purpose on such basis as the Company and Canaccord Genuity may determine. Canaccord Genuity may also, notwithstanding the above, subject to the prior consent of the Company: (i) allocate New Ordinary Shares after the time of any initial allocation to any person submitting a bid after that time, and (ii) allocate New Ordinary Shares after the bookbuild has closed to any person submitting a bid after that time. The Company reserves the right to reduce the amount to be raised pursuant to the Issue.

Application for listing and admission to trading

Application will be made to the Financial Conduct Authority for admission of the New Ordinary Shares to the premium segment of the Official List of the FCA and to London Stock Exchange plc for admission to trading of the New Ordinary Shares on its main market for listed securities (together, "Admission"). It is expected that Admission will become effective on or around 19 December 2014 and that dealings in the New Ordinary Shares on the London Stock Exchange's main market for listed securities will commence at that time.

 

* As defined in section 86(7) of the Financial Services and Markets Act 2000 (as amended).

For further information, please contact:

InfraRed Capital Partners Limited

 

Tony Roper

Keith Pickard

Robin Hubbard

+44 (0) 20 7484 1800

 

Canaccord Genuity Limited

 

Robbie Robertson

Dominic Waters

Neil Brierley

Will Barnett

Gavin Tooke

David Yovichic

 

 

+44 (0) 20 7523 8000

 

Tulchan Communications

 

Martha Walsh

 

 

+44 (0) 20 7353 4200

 

Dexion Capital (Guernsey) Limited

Carol Kilby

 

+44 (0) 1481 743943

 

 

Important Information

This Announcement has been issued by and is the sole responsibility of the Company.

 

No representation or warranty express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Canaccord Genuity Limited ("Canaccord") or by any of its respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

 

Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction.

 

This announcement and the information contained herein is not for publication, release or distribution, directly or indirectly, in or into the United States, Australia, Canada or Japan or any jurisdiction in which the same would be unlawful. This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or acquire shares in the capital of the Company in the United States, Australia, Canada or Japan or any jurisdiction in which such an offer or solicitation is unlawful.

 

Shares in HICL have not been, nor will be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any State or other jurisdiction of the United States, and accordingly may not be offered, sold or transferred within the United States except pursuant to an exemption from, or in a transaction not subject to, registration under the Securities Act. No offering of the Shares is being made in the United States or to U.S. persons as defined in and in accordance with Regulation S under the Securities Act ("U.S. Persons"). The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act") and investors will not be entitled to the benefits of that Act.

 

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for HICL Infrastructure Company Limited and is acting for no-one else in connection with the Issue.

 

InfraRed Capital Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, acts as Investment Adviser to HICL Infrastructure Company Limited and is acting for no-one else in connection with the Issue.

 

This Announcement is for information purposes only and does not constitute an invitation to subscribe for or otherwise acquire or dispose of securities in the Company in any jurisdiction. The information contained in this Announcement is for background purposes only and does not purport to be full or complete. This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase any investments nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEXLLFFZLFBFBD
Date   Source Headline
30th Apr 20247:00 amRNSNet Asset Value
22nd Apr 20247:00 amRNSNotice of Annual Results and Investor Presentation
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:21 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSInterim Update Statement
28th Feb 20247:00 amRNSDisposal and Launch of Share Buyback Programme
21st Feb 20241:39 pmRNSThird Quarterly Interim Dividend
10th Jan 20247:00 amRNSKepler Trust Intelligence: New Research
28th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSIncremental Investment in A63 Motorway for c. £20m
22nd Nov 20237:00 amRNSInterim Results 6 months ended 30th September 2023
15th Nov 202312:24 pmRNSSecond Quarterly Interim Dividend
13th Nov 20237:00 amRNSDisposal of University of Sheffield Accommodation
6th Nov 20237:00 amRNSNet Asset Value
23rd Oct 20237:00 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
28th Sep 20237:00 amRNSPortfolio Disposal for c. £204m
18th Sep 20237:00 amRNSDisposal of Bradford Schools PPPs for c. £37m
2nd Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSInterim Update Statement
25th Jul 20237:00 amRNSDirector/PDMR Shareholding
24th Jul 20237:01 amRNSDirector/PDMR Shareholding
24th Jul 20237:00 amRNSDirector/PDMR Shareholding
21st Jul 20237:00 amRNSCompletion of Hornsea II OFTO transaction
20th Jul 20237:00 amRNSKepler Trust Intelligence: New Research
19th Jul 20235:30 pmRNSResults of Annual General Meeting
19th Jul 20231:30 pmRNSReplacement Dividend Announcement
19th Jul 202312:46 pmRNSFirst Quarterly Interim Dividend
19th Jul 202311:57 amRNSFirst Quarterly Interim Dividend
19th Jul 20237:01 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSDirector/PDMR Shareholding
12th Jul 20237:00 amRNSNotice of AGM and form of proxy - correction
6th Jun 20237:00 amRNSNotice of AGM
2nd Jun 20235:55 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amRNSAnnual Results for the year ended 31 March 2023
22nd May 20237:00 amRNS£150m Private Placement debt issue
17th May 20233:30 pmRNSFourth Quarterly Interim Dividend
26th Apr 20237:00 amRNSNotice of Annual Results and Investor Presentation
25th Apr 20237:00 amRNSDisposal
5th Apr 20237:00 amRNSAcquisition Activity – French Fibre Investment
20th Mar 202310:35 amRNSHICL Announces £650m Three-Year Facility
3rd Mar 20234:04 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSInterim Update Statement
22nd Feb 20233:30 pmRNSThird Quarterly Interim Dividend
7th Feb 20237:00 amRNSUpdate on ADTiM SAS acquisition
9th Jan 20234:37 pmRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSKepler Trust Intelligence: New Research
23rd Nov 20227:00 amRNSInterim Results 6 months ended 30th September 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.